MTIM
Marathon Trading Investment Management Portfolio holdings
AUM
$167M
1-Year Return
7.67%
This Quarter Return
+4.22%
1 Year Return
+7.67%
3 Year Return
+19.9%
5 Year Return
+20.83%
10 Year Return
+48.77%
AUM
$252M
AUM Growth
-$266M
(-51%)
Cap. Flow
-$335M
Cap. Flow
% of AUM
-132.52%
Top 10 Holdings %
Top 10 Hldgs %
63.67%
Holding
320
New
109
Increased
29
Reduced
43
Closed
73
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$19.3M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
$10.5M |
| 3 |
ProShares Bitcoin Strategy ETF
BITO
|
$9.69M |
| 4 |
Amazon
AMZN
|
$6.18M |
| 5 |
Rivian
RIVN
|
$3.61M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$142M |
| 2 |
NVIDIA
NVDA
|
$98M |
| 3 |
Salesforce
CRM
|
$36.5M |
| 4 |
SPDR Gold Trust
GLD
|
$25.9M |
| 5 |
Home Depot
HD
|
$17.4M |
Sector Composition
| 1 | Financials | 37.02% |
| 2 | Technology | 12.44% |
| 3 | Consumer Discretionary | 10.78% |
| 4 | Healthcare | 7.65% |
| 5 | Communication Services | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cibus
CBUS
$66.2M
| $445K | 0.03% |
+19,823
| New | +$445K |
|
77
Starbucks
SBUX
$98.9B
| $440K | 0.03% |
4,813
+4,809
| +120,225% | +$439K |
|
|
78
SPDR Gold Trust
GLD
$110B
| $438K | 0.03% |
2,127
-125,863
| -98% | -$25.9M |
|
79
Lyft
LYFT
$6.97B
| $437K | 0.03% |
22,590
-32,950
| -59% | -$638K |
|
80
Dianthus Therapeutics
DNTH
$794M
| $435K | 0.03% |
+14,500
| New | +$435K |
|
81
Nuveen Variable Rate Preferred & Income Fund
NPFD
$474M
| $430K | 0.03% |
24,000
| – | – |
|
|
ILPT
82
Industrial Logistics Properties Trust
ILPT
$409M
| $428K | 0.03% |
+99,800
| New | +$428K |
|
83
Fulcrum Therapeutics
FULC
$372M
| $425K | 0.03% |
+45,000
| New | +$425K |
|
84
Inovio Pharmaceuticals
INO
$146M
| $421K | 0.03% |
+30,300
| New | +$421K |
|
85
Lyra Therapeutics
LYRA
$11.6M
| $417K | 0.03% |
+1,340
| New | +$417K |
|
86
Workday
WDAY
$61.7B
| $409K | 0.03% |
+1,500
| New | +$409K |
|
87
Foster
FSTR
$288M
| $406K | 0.03% |
+14,852
| New | +$406K |
|
88
TScan Therapeutics
TCRX
$107M
| $405K | 0.03% |
+51,000
| New | +$405K |
|
89
Applied Therapeutics
APLT
$67M
| $401K | 0.03% |
+59,000
| New | +$401K |
|
90
Adverum Biotechnologies
ADVM
$66.5M
| $401K | 0.03% |
+28,340
| New | +$401K |
|
91
Verastem
VSTM
$650M
| $398K | 0.03% |
+33,700
| New | +$398K |
|
92
Matrix Service
MTRX
$404M
| $397K | 0.03% |
+30,500
| New | +$397K |
|
93
Hamilton Beach Brands
HBB
$204M
| $395K | 0.03% |
+16,219
| New | +$395K |
|
|
QVCGA
94
QVC Group, Inc. Series A Common Stock
QVCGA
$79.4M
| $391K | 0.03% |
+6,360
| New | +$391K |
|
95
First Internet Bancorp
INBK
$217M
| $390K | 0.03% |
+11,222
| New | +$390K |
|
96
Shattuck Labs
STTK
$72.3M
| $387K | 0.03% |
+43,300
| New | +$387K |
|
97
Graham Corp
GHM
$540M
| $387K | 0.03% |
+14,185
| New | +$387K |
|
98
Smith-Midland
SMID
$219M
| $384K | 0.03% |
+8,183
| New | +$384K |
|
99
Aquestive Therapeutics
AQST
$612M
| $383K | 0.03% |
+90,000
| New | +$383K |
|
|
SRG
100
Seritage Growth Properties
SRG
$207M
| $383K | 0.03% |
+39,645
| New | +$383K |
|